Wendy Stock
University of Chicago · University of Chicago Comprehensive Cancer Center EDDOP · University of Chicago Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wendy Stock as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:36 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07405424 · Spiritual Care Intervention in Adult Patients Diagnosed With Acute LeukemiaUniversity of Chicago · recruiting · Leukemia · principal investigator
- N/ANCT06785324 · Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)University of Chicago · recruiting · Philadelphia Chromosome Negative, B Cell Acute Lymphoblastic Leukemia (B-ALL), B-ALL · principal investigator
- N/ANCT05458258 · Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid LeukemiaUniversity of Chicago · completed · Acute Myeloid Leukemia, Leukemia, Myeloid · principal investigator
- Ph2NCT04747912 · Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)University of Chicago · recruiting · Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia · principal investigator
- Ph1NCT03571321 · Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic LeukemiaUniversity of Chicago · recruiting · Acute Lymphoblastic Leukemia, ALL, Childhood, ALL · principal investigator
- Ph2NCT02275533 · Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN TrialNational Cancer Institute (NCI) · active not recruiting · Acute Myeloid Leukemia · principal investigator
- N/ANCT01004640 · Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical TrialAlliance for Clinical Trials in Oncology · unknown · Leukemia · study chair
- Ph2NCT00724009 · Clofarabine Bone Marrow CytoreductionUniversity of Chicago · completed · Leukemia · principal investigator
- Ph2NCT00558519 · Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaAlliance for Clinical Trials in Oncology · completed · Leukemia · study chair
- Ph2NCT00419081 · Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment RegimensBioCryst Pharmaceuticals · terminated · Leukemia, Lymphoma · principal investigator
- Ph2NCT00303966 · Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI) · terminated · Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia · principal investigator
- Ph1/Ph2NCT00144963 · Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaAcrotech Biopharma Inc. · completed · Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT00003700 · Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaAlliance for Clinical Trials in Oncology · completed · Leukemia · study chair
- Ph1/Ph2NCT00061945 · Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI) · completed · Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia · principal investigator
- N/ANCT00003861 · Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic LeukemiaAlliance for Clinical Trials in Oncology · active not recruiting · Leukemia, Acute Lymphoblastic Leukemia, Acute Promyelocytic Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical and Experimental TherapeuticsP30CA014599 · NCI · UNIVERSITY OF CHICAGO · fiscal years 2008 to 2026 · $208,802 awarded in 2026Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- North American Star ConsortiumUM1CA186644 · NCI · UNIVERSITY HEALTH NETWORK · PI Philippe Bedard, Kevin D Courtney, Steven Grant, Salma Jabbour, Jeffrey Lancet, Devalingam Mahalingam, Lillian L Siu, JONATHAN C TRENT · fiscal years 2014 to 2026Named on NCT02275533
- NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 EmphasisUM1CA186686 · NCI · MAYO CLINIC ROCHESTER · PI ALEX A. ADJEI · fiscal years 2014 to 2019Named on NCT02275533
- Supplement to Extend Funds for Grant #UM1CA186689 VICKtOrY Early Clinical Trials ConsortiumUM1CA186689 · NCI · YALE UNIVERSITY · PI Patricia M. LoRusso · fiscal years 2014 to 2026Named on NCT02275533
- The Johns Hopkins Translational Science Team and Consortium for ETCTN StudiesUM1CA186691 · NCI · JOHNS HOPKINS UNIVERSITY · PI Jan Hendrik Beumer, Michael A Carducci, Ryan Gentzler, GLENN LIU, Wells A. Messersmith, Jimmy Ruiz · fiscal years 2014 to 2026Named on NCT02275533
- The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials NetworkUM1CA186712 · NCI · OHIO STATE UNIVERSITY · PI SUSANNE M ARNOLD, WILLIAM E. CARSON, Narendranath Epperla · fiscal years 2014 to 2026Named on NCT02275533
- Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTNUM1CA186717 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI A. Dimitrios Colevas, Alexey V. Danilov, PRIMO N. LARA, HEINZ JOSEF LENZ · fiscal years 2014 to 2026Named on NCT02275533
- Cancer and Leukemia Group BU10CA031946 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 1985 to 2013
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT01004640
- ACOSOG Competing RenewalU10CA076001 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 1998 to 2013Named on NCT00003861
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:36 UTC. The ranking covers the 200 most relevant of 120 PubMed records, and a shared surname and initials can bring in a namesake. All 120 on PubMed
- 1,127 citationsRCR 36.3
- TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.N Engl J Med · 2016724 citationsRCR 21.4
- 439 citationsRCR 10.1
- 429 citationsRCR 16.8
- 309 citationsRCR 7.6
- 298 citationsRCR 11.8
- Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.Cancer Discov · 2021267 citationsRCR 14.2
- 235 citationsRCR 6.5
- A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies.Clin Cancer Res · 2008198 citationsRCR 4.0
- Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.J Clin Oncol · 2009161 citationsRCR 3.7